Wednesday, April 27, 2022 9:13:48 AM
Operating Expenses
Operating expenses increased to $4,657,818 for the year ended December 31, 2021, from to $2,146,047 for the year ended December 31, 2020. The detail by major category is reflected in the table below.
Sales and marketing costs increased by $1,659,274 for the year ended December 31, 2021, primarily due to the fair value of options issued pursuant to a consulting and real estate sales agreement, which were granted during the year ended December 31, 2021. The Company also granted common shares with a fair value of approximately $447,000 with regards to consulting and advisory services on M&A, marketing & promotions of the Company real estate projects.
General and administrative costs increased by $852,497 for the year ended December 31, 2021, primarily due to compensation expense resulting from new employment contracts for our President, investors relations, and stock-based compensation.
They call me Lazarous!
Recent ILAL News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 08:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/09/2024 08:41:40 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 05:39:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/22/2023 08:58:22 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2023 08:41:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 10:14:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 04:56:42 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/17/2023 08:16:35 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM